Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

MTX treatment break improves COVID-19 booster response in patients with IMIDs
18 Aug 2022
bởiAudrey Abella
In individuals with immune-mediated inflammatory diseases (IMIDs*), a 2-week interruption in methotrexate (MTX) treatment led to enhanced COVID-19 booster vaccine response compared with those who continued with MTX treatment, according to findings from the VROOM** study.
18 Aug 2022

Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
18 Aug 2022
bởiTristan Manalac
In men with intermediate- or high-risk prostate cancer (PCa), local failure after definitive radiation therapy (RT) is indicative of survival outcomes, according to a recent study.
18 Aug 2022






